World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
27787
World Ranking
16985
National Ranking
679

Overview

Diana Giannarelli is affiliated with Sapienza University of Rome in Italy and has made significant contributions in the field of Medicine, with a particular focus on Oncology. Their research spans various subfields including Oncology, Pulmonary and Respiratory Medicine, Genetics, Reproductive Medicine, and Surgery.

Their work covers key topics such as:

  • Cancer Immunotherapy and Biomarkers
  • Ovarian cancer diagnosis and treatment
  • Chronic Lymphocytic Leukemia Research
  • Endometrial and Cervical Cancer Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Lung Cancer Treatments and Mutations
  • CAR-T cell therapy research

Frequent co-authors collaborating with Diana Giannarelli include:

  • Giovanni Scambia
  • Anna Fagotti
  • Paolo A. Ascierto
  • Emilio Bria
  • Alessandra Fabi

Their research has been published across notable venues such as:

  • International Journal of Gynecological Cancer
  • Annals of Oncology
  • Journal of Clinical Oncology
  • Cancers
  • ESMO Open

Some recent papers authored or co-authored by Diana Giannarelli include:

  • Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial, 2022, Journal of Clinical Oncology
  • Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine, 2021, EClinicalMedicine
  • Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution, 2021, Journal of Hematology & Oncology
  • Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL), 2020, Leukemia
  • FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma, 2021, Journal of Hepatology

Best Publications

  • Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

    Pierluigi Benedetti Panici;Stefano Basile;Francesco Maneschi;Andrea Alberto Lissoni

  • Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial

    Pierluigi Benedetti Panici;Angelo Maggioni;Neville Hacker;Fabio Landoni

  • Neoadjuvant Chemotherapy and Radical Surgery Versus Exclusive Radiotherapy in Locally Advanced Squamous Cell Cervical Cancer: Results From the Italian Multicenter Randomized Study

    Pierluigi Benedetti-Panici;Stefano Greggi;Alessandro Colombo;Mariangela Amoroso

  • Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

    Mariaelena Capone;Diana Giannarelli;Domenico Mallardo;Gabriele Madonna

  • Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

    Luana Calabrò;Aldo Morra;Ester Fonsatti;Ornella Cutaia

  • Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.

    Luisa Carbognin;Sara Pilotto;Michele Milella;Vanja Vaccaro

  • Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

    Antonio M Grimaldi;Ester Simeone;Diana Giannarelli;Paolo Muto

  • Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

    P.F. Ferrucci;P.A. Ascierto;J. Pigozzo;M. Del Vecchio

  • Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features

    Francesca R. Mauro;Robert Foa;Raffaella Cerretti;Diana Giannarelli

  • Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases.

    Francesca R. Mauro;Robert Foa;Robert Foa;Diana Giannarelli;Diana Giannarelli;Iole Cordone;Iole Cordone

  • Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

    A. Pace;A. Vidiri;E. Galiè;M. Carosi

  • Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

    Anna Maria Di Giacomo;Paolo A. Ascierto;Lorenzo Pilla;Mario Santinami

  • Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

    Ester Simeone;Giusy Gentilcore;Diana Giannarelli;Antonio M. Grimaldi

  • Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

    F. Cognetti;E. M. Ruggeri;A. Felici;M. Gallucci

  • Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study.

    Luana Calabrò;Aldo Morra;Diana Giannarelli;Giovanni Amato

  • Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial

    A. Pace;D. Giannarelli;E. Galiè;A. Savarese

  • Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

    P F Ferrucci;S Gandini;A Battaglia;S Alfieri

  • Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.

    P G Natali;C V Hamby;B Felding-Habermann;B Liang

  • Prevention of VTE in orthopedic surgery patients

    Federico Spandonaro;Rossella Letizia Mancusi;Lorenzo Terranova;Diana Giannarelli

  • Neoadjuvant C hemotherapy a nd R adical S urgery V ersus Exclusive R adiotherapy i n L ocally A dvanced S quamous C ell Cervical C ancer: R esults F rom t he I talian M ulticenter Randomized S tudy

    Pierluigi Benedetti-Panici;Stefano Greggi;Alessandro Colombo;Mariangela Amoroso

Frequent Co-Authors

Francesco Cognetti
Francesco Cognetti Sapienza University of Rome
Michele Maio
Michele Maio University of Siena
Michele Milella
Michele Milella University of Verona
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Marcella Mottolese
Marcella Mottolese IRCCS Regina Elena Institute
Giampaolo Tortora
Giampaolo Tortora University of Verona
Gennaro Ciliberto
Gennaro Ciliberto Magna Graecia University
Giuseppe Palmieri
Giuseppe Palmieri National Academies of Sciences, Engineering, and Medicine
Ugo De Giorgi
Ugo De Giorgi The University of Texas MD Anderson Cancer Center
Manlio Ferrarini
Manlio Ferrarini University of Genoa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in healthcare careers beyond a traditional MD pathway, a variety of online degree programs are available in the USA. Many registered nurses pursue advanced qualifications to boost their skills and marketability. For example, online rn to bsn programs no clinicals allow nurses to earn a Bachelor’s degree without the need for additional clinical placements, making these programs more accessible and flexible.

For those looking to advance further, doctoral-level programs in nursing are also available online. Some may choose short dnp programs designed for experienced nurses seeking to become clinical experts or move into leadership roles quickly. Meanwhile, others might look for dnp programs that are renowned for being manageable while still offering rigorous training and quality accreditation.

Aspiring nurses who are eager to join the workforce rapidly can consider fast-track diploma pathways like the 6 month lpn program, which provide a quicker route to licensure and employment in practical nursing roles. Each pathway has unique requirements, timeframes, and outcomes, offering candidates a range of academic and career options in the medical field.

Best Scientists Citing Diana Giannarelli

Trending Scientists

Recently Published Articles